Recent Updates
Recently added Catalysts
IMRX Positive Sentiment

Peter Feinberg

Key Takeaway: Mr. Peter Feinberg has been a member of the Board of Directors since January 2021. He is a founding member of Boxcar Partners and has significant experience in biotechnology through various leadership roles in multiple companies. His background includes over three decades in financial services, enhancing his qualifications in the biotech sector.
Price reaction · baseline $6.73 (2025-12-26 close) · 5 other IMRX headline(s) in the window, move may be shared
day 0 close · peak
-1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Mr. Feinberg has extensive experience in biotechnology investing.
  • He is involved in multiple successful biotech ventures.
  • His leadership roles indicate strong industry influence.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+41%
120-day peak, hindsight
Typical move
11.4%
average across 8 past catalysts
Cash runway
~36 mo
Minimal dilution risk
Lead asset
IMM-1-104 Monotherapy
Phase 1 · Advanced Solid Tumor

Full Press Release Details

Mr. Feinberg has served on our Board of Directors since January 2021. Mr. Feinberg was a Founding Member of Boxcar Partners, a venture capital investment firm with a focus on biotechnology investing, and has served as Partner there since 2019. Mr. Feinberg is also a Founder of Sporos Bioventures, LLC, a private biotechnology company focused on transforming the drug development process across oncology. In addition, he currently serves as Co-Founder of BridgeBio Pharma, Inc., a publicly traded biotechnology company focusing on genetic diseases, Boxcar PMJ LP and Emerging Security Solutions. He has more than three decades of experience in the financial services industry at Oppenheimer & Co. Inc. where he served as a Managing Director. Mr. Feinberg served on the board of directors of Notable Labs, LTD., a publicly traded biotechnology company, from September 2023 to October 2024. Mr. Feinberg received his B.S. in finance from Whittier College.

Frequently Asked Questions

What positions does Peter Feinberg hold?

Peter Feinberg serves on the Board of Directors of IMRX and is a partner at Boxcar Partners.

What is Boxcar Partners?

Boxcar Partners is a venture capital firm focusing on biotechnology investments.

What is Sporos Bioventures, LLC?

Sporos Bioventures is a private biotechnology company aimed at improving drug development.

What is BridgeBio Pharma, Inc.?

BridgeBio Pharma is a publicly traded company that focuses on genetic diseases.

Last updated: Dec 27, 2025